# Slate Medicines funding rounds and investors

As of 14 Oct 2026, Slate Medicines has raised $130M across 1 verified round on record; latest: $130 million Series A led by Forbion, Foresite Capital and 1 other, announced 24 Feb 2026.

Next-generation therapeutics for migraine and headache disorders targeting pathways involved in migraine pathophysiology.

Website: https://slatemedicines.com  
Page: https://fireround.dev/companies/slatemedicines.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-02-24 | Series A | $130 million | Forbion, Foresite Capital, RA Capital Management | none named | [businesswire.com](https://www.businesswire.com/news/home/20260224047796/en/Slate-Medicines-Launches-with-%24130-Million-Series-A-Financing-to-Advance-Anti-PACAP-Therapies-for-the-Prevention-of-Migraine-and-Other-Headache-Disorders) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.